Olofsson, A., Ichijo, H. Moren, A., ten Dijke, P., Miyazono, K. and Heldin, C.-H.
Efficient association of an amino-terminally extended form of human latent transforming growth factor-β binding protein (LTBP-1) with the extracellular matrix.
J. Biol. Chem., 270, 31294-31297 (1995).

  Iseki, S., Osumi-Yamashita, N., Miyazono, K., Franzen, P., Ichijo, H., Ohtani, H., Hayashi, Y. and Eto, K.
Localization of transforming growth factor-β type I and type II receptors in mouse development.
Exp. Cell Res., 219, 339-347 (1995).

  Ishisaki, A., Oida, S., Momose, F., Amagasa, T., Rikimaru, K., chijo, H. and Sasaki, S.
Identification and characterization of autocrine motility factor-like activity in oral squamous-cell- carcinoma cells.
Int. J. Cancer, 59, 783-788 (1994).

  Iimura, T., Oida, S., Ichijo, H., Goseki, M., Maruoka, Y., Takeda, K. and Sasaki, S. 
Moduration of responses to TGF-β by 1, 25 Dihydroxyvitamin D3 in MG-63 osteoblastic cells.
Biochem. Biophys. Res. Commun., 204, 918-923 (1994).

  Takeda, K., Oida, S., Ichijo, H., Iimura, T., Maruoka, Y., Amagasa, T. and Sasaki, S.
Molecular cloning of rat bone morphogenetic protein (BMP) type IA receptor and its expression during ectopic bone formation induced by BMP.
Biochem. Biophys. Res. Commun., 204, 203-209 (1994).

  ten Dijke, P., Yamashita, H., Sampath, K., Reddi, H., Riddle, D., Ichijo, H., Heldin, C.-H. and Miyazono, K.
Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4.
J. Biol. Chem., 269, 16985-16988 (1994).

  Taketazu, F., Kato, M., Gobl, A., Ichijo, H., ten Dijke, P., Itoh, J. Kyogoku, M., Ronnelid, J.,  Miyazono, K., Heldin, C.-H. and Funa, K.
Enhanced expression of transforming growth factor-βs and transforming growth factor-β type II receptor in the synovial tissues of patients with rheumatoid arthritis.
Lab. Invest., 70, 620-630 (1994).

  ten Dijke, P., Yamashita, H., Ichijo, H., Franzen, P., Laiho, M., Miyazono, K. and Heldin, C.-H.
Characterization of type I receptors for transforming growth factor-β and activin.
Science, 264, 101-104 (1994).

  Yamashita, H., Ichijo, H., Grimsby, S., Moren, A., ten Dijke, P. and Miyazono, K.
Endoglin forms a heteromeric complex with the signalling receptors for transforming growth factor-β.
J. Biol. Chem., 269, 1995-2001 (1994).

  Ichijo, H., Yamashita, H., ten Dijke, P., Eto, Y., Heldin, C.-H. and Miyazono, K.
Characterization of in vivo phosphorylation of activin type II receptor.
Biochem. Biophys. Res. Commun., 194, 1508-1514 (1993).

  Franzen, P., ten Dijke, P., Ichijo, H., Yamashita, H., Schulz, P., Heldin, C.-H. and Miyazono, K.
Cloning of a TGF-β type I receptor that forms a heteromeric complex with the TGF-β type II receptor.
Cell, 75, 681-692 (1993).

  ten Dijke, P., Ichijo, H., Franzen, P., Schultz, P., Saras, J., Toyoshima, H., Heldin, C.-H. and Miyazono, K.
Activin receptor-like kinases: a novel subclass of cell surface receptors with predicted serine/threonine kinase activiy.
Oncogene, 8, 2879-2887 (1993).

  Franzen P., Ichijo, H. and Miyazono, K.
Different signals mediate transforming growth factor-β 1-induced growth inhibition and extracellular matrix production in prostatic carcinoma cells.
Exp. Cell Res., 207, 1-7 (1993).

  Ichijo, H., Hellman, U., Wernstedt, C., Gonez, L.-J., Claesson-Welsh, L., Heldin, C.-H. and Miyazono, K.
Molecular cloning and characterization of ficolin, a multimeric protein with fibrinogen- and collagen-like domains.
J. Biol. Chem., 268, 14505-14513 (1993).

  Moren, A., Ichijo, H. and Miyazono, K.
Molecular cloning and characterization of the human and porcine transforming growth factor-β type III Receptors.
Biochem. Biophys. Res. Commun., 189, 356-362 (1992).

  Taketazu, F., Miyagawa, K.,Ichijo, H., Oshimi, K., Mizoguchi, H., Hirai, H., Miyazono, K. and Takaku, F.
Decreased level of transforming growth factor-β in blood lymphocytes of patients with aplastic anemia.
Growth Factors, 6, 85-90 (1992).

  Ichijo, H., Ronnstrand, L., Miyagawa, K., Ohashi, H., Heldin, C.-H. and Miyazono, K.
Purification of transforming growth factor-β1 binding proteins from porcine uterus membranes.
J. Biol. Chem., 266, 22459-22464 (1991).

  Piao, Y.-F., Ichijo, H., Miyagawa, K., Ohashi, H., Takaku, F. and Miyazono, K.
Latent form of transforming growth factor-β1 acts as a potent growth inhibitor on a human erythroleukemia cell line.
Biochem. Biophys. Res. Commun., 167, 27-32 (1990).

  Ichijo, H., Momose, F. and Miyazono, K.
Biological effects and binding properties of transforming growth factor-β on human oral squamous cell carcinoma cells.
Exp. Cell Res., 187, 263-269 (1990).

  Momose, F. Araida, T., Negishi, A., Ichijo, H., Shioda, S. and Sasaki, S.
Variant sublines with different metastatic potentials selected in nude mice from human oral squamous cell carcinomas.
J. Oral Pathol. Med., 18, 391-395 (1989).

Review articles

  ten Dijke, P., Franzen, P., Yamashita, H., Ichijo, H., Heldin, C.-H. and Miyazono, K.
Serie/threonine kinase receptors.
Progress in Growth Factor Research (review article), 5, 55-72 (1994).

  Miyazono, K., ten Dijke, P., Ichijo, H. and Heldin, C.-H.
Receptors for transforming growth factor-β.
Advances in Immunology (Dixon,F.J. ed., Academic Press,Inc.), (review article) 55, 181-220 (1994).

  Miyazono, K., Ichijo, H. and Heldin, C.-H.
Transforming growth factor-β: latent forms, binding proteins and receptors.
Growth Factors (review article), 8, 11-22 (1993).